Summary
A placebo-controlled, double-blind study was carried out over 4 months to evaluate two doses of synthetic human calcitonin (0.25 and 0.125 mg) given s.c. three times per week. Enrolled were 60 women, aged 56–82 years, who had experienced a vertebral fracture due to low-energy trauma within the preceding year. During active treatment there was within the first month a dose-dependent decrease of the indices of bone resorption (fasting urinary calcium and hydroxyproline excretions), whereas only the higher dose and a treatment period of 4 months produced a reduction of bone formation (serum osteocalcin). The bone mineral content (BMC) of the nondominant forearm was unchanged. Treatment with calcitonin also had significant, dosedependent, analgetic effects. The amelioration of pain was, in multivariate analyses, related to a reduction in parameters felt to be markers for bone resorption. In the placebo group there was a significant reduction of the BMC of the forearm but no changes of any of the biochemical markers for bone turnover and no improvement of pain. In conclusion, treatment with two low doses of calcitonin induced changes of the biochemical markers of bone turnover in a dosedependent manner. The analgetic properties of calcitonin were also of salient clinical importance. The knowledge derived from this study could be adapted to the dosage schedule in long-term trials in osteoporosis.
Similar content being viewed by others
References
Austin LA, Heath H III. (1981) Calcitonin: physiology and patophysiology. N Engl J Med 304:269–278
Hurley DL, Tiegs RD, Wahner HW, Heath H III (1987) Axial and appendicular bone mineral density in patients with longterm deficiency or excess of calcitonin. N Engl J Med 317:537–541
Gennari C, Chierichetti SM, Piolini M, Vibelli C, Agnusdei D (1985) Analgesic activity of salmon and human calcitonin against cancer pain: a double-blind placebo-controlled clinical study. Curr Ther Res 38:298–308
MacIntyre I, Stevenson JC, Whitehead MI, Wimalawansa SJ, Banks LM, Haly MJR (1988) Calcitonin for prevention of postmenopausal bone loss. Lancet i:900–902
Reginster JY, Denis D, Albert A, Deroisy R, Lecart MP, Fontaine MA, Lambelin P, Franchimont P (1987) 1-year controlled trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet ii:1481–1483
Fatourechi V, Heath III (1987) Salmon calcitonin in the treatment of postmenopausal osteoporosis (Editorial). Ann Int Med 107:923–925
Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut CH III (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295–303
Gennari C, Chierichetti SM, Bigazzi S, Fusi L, Gonnelli S, Ferrara R, Zacchei F (1985) Comparative effects on bone mineral content of calcium and calcium plus calcitonin given in two different regimens in postmenopausal osteoporosis. Curr Ther Res 38:455–464
Mazzuoli GF, Passeri M, Gennari C (1986) Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled doubleblind clinical study. Calcif Tiss Int 38:3–8
Aloia JF, Vaswani A, Kapoor A, Yeh K, Cohn SH (1985) Treatment with calcitonin with or without growth hormone. Metabolism 34:129–134
Eriksen EF (1986) Normal and pathological remodelling of human trabecular bone: three-dimensional reconstruction of the remodelling cycle in normals and in metabolic bone disease. Endocr Rev 7:379–408
Westlin NE (1974) Loss of bone mineral after Colles' fracture. Clin Orthop 102:194–199
Fischer JA, Tobler PH, Henke H, Tschopp FA (1983) Salmon and human calcitonin-like peptides coexist in the human thyroid and brain. J Clin Endocrinol Metab 57:1314–1316
Fraioli F, Fabbri A, Gnessi L, Moretti C, Santoro C, Felici M (1982) Subarachnoid injection of salmon calcitonin induces analgesia in man. Europ J Pharmacol 78:381–382
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ljunghall, S., Gärdsell, P., Johnell, O. et al. Synthetic human calcitonin in postmenopausal osteoporosis: A placebo-controlled, double-blind study. Calcif Tissue Int 49, 17–19 (1991). https://doi.org/10.1007/BF02555897
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02555897